A gonadotropin-releasing hormone antagonist reduces serum adrenal androgen levels in prostate cancer patients

BACKGROUND: Adrenal androgens play an important role in the development of castration-resistant prostate cancer therapeutics. The effect of gonadotropin-releasing hormone (GnRH) antagonists on adrenal androgens has not been studied sufficiently. We measured testicular and adrenal androgen levels in...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazawa, Yoshiyuki, Sekine, Yoshitaka, Syuto, Takahiro, Nomura, Masashi, Koike, Hidekazu, Matsui, Hiroshi, Shibata, Yasuhiro, Ito, Kazuto, Suzuki, Kazuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575925/
https://www.ncbi.nlm.nih.gov/pubmed/28851333
http://dx.doi.org/10.1186/s12894-017-0261-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5575925/
https://www.ncbi.nlm.nih.gov/pubmed/28851333
http://dx.doi.org/10.1186/s12894-017-0261-z

Ejemplares similares